Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Lavee, J; Mulzer, J; Krabatsch, T; Marasco, S; McGiffin, D; Garbade, J; Schmitto, JD; Zimpfer, D; Potapov, EV.
An international multicenter experience of biventricular support with HeartMate 3 ventricular assist systems.
J Heart Lung Transplant. 2018; 37(12):1399-1402
Doi: 10.1016/j.healun.2018.08.008
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
-
Zimpfer Daniel
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Significant right ventricular failure accompanying left ventricular failure was treated by implantation of the fully magnetically levitated centrifugal HeartMate 3 ventricular assist device as biventricular (BiVAD) support in 14 patients at 6 medical centers worldwide. The clinical details of this first multicenter experience are presented. Nine of these patients (64%) were alive as of January 1, 2018. Eight of the 9 have continued on BiVAD support for 95 to 636 (mean 266) days: 7 at home, and 1 successfully transplanted after 98 days of support.
- Find related publications in this database (using NLM MeSH Indexing)
-
Adolescent - administration & dosage
-
Adult - administration & dosage
-
Aged - administration & dosage
-
Cardiomyopathies - mortality, therapy
-
Equipment Design - administration & dosage
-
Female - administration & dosage
-
Germany - administration & dosage
-
Heart Failure - mortality, therapy
-
Heart-Assist Devices - administration & dosage
-
Humans - administration & dosage
-
Male - administration & dosage
-
Middle Aged - administration & dosage
-
Prognosis - administration & dosage
-
Survival Rate - administration & dosage
-
Young Adult - administration & dosage
- Find related publications in this database (Keywords)
-
bi-ventricular assist device
-
bi-ventricular failure
-
continuous flow ventricular assist device
-
left ventricular assist device
-
right ventricular assist device
-
total artificial heart